The role of macrophages and mast cells in lymphangiogenesis and angiogenesis in cervical carcinogenesis

Experimental and Molecular Pathology

Volumn 89, Issue 2, 2010, Pages 190-196

  Utrera Barillas, Dolores ^a   Castro Manrreza, Marta ^a   Castellanos, Emilio ^a   Gutiérrez Rodríguez, Margarita ^b   Arciniega Ruíz de Esparza, Olga ^c   García Cebada, Juan ^d   Velazquez, Juan R ^d   Flores Reséndiz, David ^a   Hernández Hernández, Dulce ^a   Benítez Bribiesca, Luis ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Angiogenesis; Cervical cancer; Lymphangiogenesis; Macrophages; Mast cells

Indexed keywords

ARTICLE; BLOOD VESSEL; CARCINOGENESIS; CELL DENSITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH VESSEL; LYMPHANGIOGENESIS; MACROPHAGE; MAJOR CLINICAL STUDY; MAST CELL; TUMOR VASCULARIZATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; CARCINOMA IN SITU; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; UTERINE CERVIX TUMOR; VASCULARIZATION;

CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; LYMPHANGIOGENESIS; MACROPHAGES; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC; UTERINE CERVICAL NEOPLASMS;

EID: 77956425861     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.06.002     Document Type: Article

References (46)

1. Allavena P., Sica A., Garlanda C., Mantovani A. The yin-yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 2008, 222:155-161.
2. Aubry K., Barriere G., Chable-Rabinovitch H., Dutour A., Paraf F., Monteil J., Rigaud M. Molecular mechanisms regulating the angiogenic phenotype in tumors: clinical impact in the future. Anticancer Res. 2007, 27:3111-3119.
3. Benítez-Bribiesca L., Wong A., Utrera D., Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J. Histochem. Cytochem. 2001, 49:1061-1062.
4. Boneberg E.M., Legler D.F., Hoefer M.M., Ohlschlegel C., Steininger H., Füzesi L., Beer G.M., Dupont-Lampert V., Otto F., Senn H.J., Fürstenberger G. Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. Br. J. Cancer 2009, 101:605-614.
5. Cabanillas-Sáez A., Schalper J.A., Nicovani S.M., Rudolph M.I. Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int. J. Gynecol. Cancer 2002, 12:92-98.
6. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
7. Davidson B., Goldberg I., Gotlieb W.H., Lerner-Geva L., Ben-Baruch G., Agulansky L., Novikov I., Kopolovic J. Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma-clinicopathologic correlation. Acta Obstet. Gynecol. Scand. 1999, 78:240-244.
8. Deininger M.H., Meyermann R. Multiple epitope labeling by the exclusive use of alkaline phosphatase conjugates in immunohistochemistry. Histochem. Cell Biol. 1998, 110:425-430.
9. Eccles S., Paon L., Sleeman J. Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms. Clin. Exp. Metastasis 2007, 24:619-636.
10. Falk S., Falk C., Stutte H.J. Local immune reactions in carcinoma in situ and cervix cancer-a histologic and immunohistochemical study. Geburtshilfe Frauenheilkd 1991, 51:39-44.
11. Fregnani J.H., Soares F.A., Novik P.R., Lopes A., Latorre M.R. Intensity of cervical inflammatory reaction as a risk factor for recurrence of carcinoma of the uterine cervix in stages IB and IIA. São Paulo Med. J. 2007, 125:231-236.
12. Fujimoto J., Sakaguchi H., Aoki I., Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res. 2000, 60:2632-2635.
13. Gao P., Zhou G.Y., Yin G., Liu Y., Liu Z.Y., Zhang J., Hao C.Y. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma. Hum. Pathol. 2006, 37:719-725.
14. Gocheva V., Wang H.W., Gadea B.B., Shree T., Hunter K.E., Garfall A.L., Berman T., Joyce J.A. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010, 24:241-255.
15. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
16. Hammes L.S., Tekmal R.R., Naud P., Edelweiss M.I., Kirma N., Valente P.T., Syrjänen K.J., Cunha-Filho J.S. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression-clinicopathological correlation. Gynecol. Oncol. 2007, 105:157-165.
17. Hammes L.S., Tekmal R.R., Naud P., Edelweiss M.I., Kirma N., Valente P.T., Syrjänen K.J., Cunha-Filho J.S. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Gynecol. Oncol. 2008, 110:445-451.
18. Heller D.S., Hameed M., Cracchiolo B., Wiederkehr M., Scott D., Skurnick J., Ammar N., Lambert W.C. Presence and quantification of macrophages in squamous cell carcinoma of the cervix. Int. J. Gynecol. Cancer 2003, 13:67-70.
19. Jach R., Dulinska-Litewka J., Laidler P., Szczudrawa A., Kopera A., Szczudlik L., Pawlik M., Zajac K., Mak M., Basta A. Expression of VEGF, VEGF-C and VEGFR-2 in in situ and invasive SCC of cervix. Front. Biosci. 2010, 2:411-423.
20. Jeon B.H., Jang C., Han J., Kataru R.P., Piao L., Jung K., Cha H.J., Schwendener R.A., Jang K.Y., Kim K.S., Alitalo K., Koh G.Y. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res. 2008, 68:1100-1109.
21. Johnson L.A., Prevo R., Clasper S., Jackson D.G. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 2007, 282:33671-33680.
22. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
23. Karamysheva A.F. Mechanisms of angiogenesis. Biochemistry (Mosc). 2008, 73:751-762.
24. Karpanen T., Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu. Rev. Pathol. 2008, 3:367-397.
25. Kobayashi A., Weinberg V., Darragh T., Smith-McCune K. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol. 2008, 1:412-420.
26. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., Qian H., Xue X.N., Pollard J.W. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006, 66:11238-11246.
27. Longatto-Filho A., Pinheiro C., Pereira S.M., Etlinger D., Moreira M.A., Jubé L.F., Queiroz G.S., Baltazar F., Schmitt F.C. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol. Oncol. 2007, 107:45-51.
28. Mazibrada J., Rittà M., Mondini M., De Andrea M., Azzimonti B., Borgogna C., Ciotti M., Orlando A., Surico N., Chiusa L., Landolfo S., Gariglio M. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol. Oncol. 2008, 108:112-120.
29. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010, 140:771-776.
30. O'Leary T.J. Standardization in immunohistochemistry. Appl. Immunohistochem. Mol. Morphol. 2001, 9:3-8.
31. Ostör A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol. 1993, 12:186-192.
32. Phoophitphong T., Hanprasertpong J., Dechsukhum C., Geater A. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection. J. Obstet. Gynaecol. Res. 2007, 33:840-848.
33. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
34. Raica M., Cimpean A.M., Nico B., Guidolin D., Ribatti D. A comparative study of the spatial distribution of mast cells and microvessels in the foetal, adult human thymus and thymoma. Int. J. Exp. Pathol. 2010, 91:17-23.
35. Randall L.M., Monk B.J., Darcy K.M., Tian C., Burger R.A., Liao S.Y., Peters W.A., Stock R.J., Fruehauf J.P. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol. Oncol. 2009, 112:583-589.
36. Ribatti D., Crivellato E. The controversial role of mast cells in tumor growth. Int. Rev. Cell Mol. Biol. 2009, 275:89-131.
37. Roskoski R. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit. Rev. Oncol. Hematol. 2007, 62:179-213.
38. Schoppmann S.F., Birner P., Stöckl J., Kalt R., Ullrich R., Caucig C., Kriehuber E., Nagy K., Alitalo K., Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 2002, 161:947-956.
39. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 2009, 86:1065-1073.
40. Srivani R., Nagarajan B. A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int. J. Gynecol. Cancer 2003, 13:331-339.
41. Takehara K. Local immune responses in uterine cervical carcinogenesis. Nippon Sanka Fujinka Gakkai Zasshi 1996, 48:1063-1070.
42. Van Trappen P.O., Steele D., Lowe D.G., Baithun S., Beasley N., Thiele W., Weich H., Krishnan J., Shepherd J.H., Pepper M.S., Jackson D.G., Sleeman J.P., Jacobs I.J. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J. Pathol. 2003, 201:544-554.
43. Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T.V., Kubo H., Thurston G., McDonald D.M., Achen M.G., Stacker S.A., Alitalo K. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 2001, 20:1223-1231.
44. Zhang S.Q., Yu H., Zhang L.L. Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method study. BMC Cancer 2009, 9:64.
45. Zhu X.Q., Lv J.Q., Lin Y., Xiang M., Gao B.H., Shi Y.F. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells. Gynecol. Oncol. 2007, 105:650-656.
46. Zusterzeel P.L., Span P.N., Dijksterhuis M.G., Thomas C.M., Sweep F.C., Massuger L.F. Serum vascular endothelial growth factor: a prognostic factor in cervical cancer. J. Cancer Res. Clin. Oncol. 2009, 135:283-290.